Unternehmensübersicht
Global Medical REIT Inc. operates as a specialized net-lease medical real estate investment trust that acquires healthcare facilities and subsequently leases these properties to physician groups, regional healthcare systems, and national health networks. This operational model places the company firmly within the Real Estate sector, specifically the REIT - Healthcare Facilities industry, where the primary business activity involves generating rental income from medical infrastructure rather than direct patient care services. The entity currently maintains a market capitalization of $979.78M and employs a workforce of 26 individuals to support its portfolio management and leasing operations. With an annual revenue of $144.83M, the company's financial scale suggests a significant presence in the specialized healthcare real estate market, positioning it as a substantial player capable of influencing supply dynamics for medical tenants across its operational footprint.
Finanzielle Gesundheit
The company reported a trailing twelve-month revenue of $144.83M, while net income stood at $-3,324,000, revealing a substantial disparity between top-line growth and bottom-line profitability that highlights the high fixed cost structure inherent in real estate operations. Despite the negative net income, the entity generated an EBITDA of $87.53M, indicating that operational cash generation remains robust before the deduction of interest, taxes, depreciation, and amortization. Free cash flow is reported at $66.02M, which provides the organization with significant financial flexibility to service its debt obligations or fund capital improvements without relying on external financing. The gross margin stands at 99.9%, reflecting the cost-effective nature of the net-lease model where most operational expenses are borne by tenants, while the operating margin of 24.5% and profit margin of 1.7% demonstrate the specific impact of interest expenses on the final net income. The balance sheet shows cash holdings of $14.59M against total debt of $723.14M, resulting in a debt-to-equity ratio of 142.96 that characterizes a highly leveraged capital structure typical for REITs. Current liquidity is supported by a current ratio of 1.91, suggesting that short-term assets are nearly double the short-term liabilities, providing a comfortable buffer for immediate obligations. Return on equity is calculated at 0.4% and return on assets at 1.7%, metrics that indicate that, in the current accounting environment, management effectiveness in generating returns on the invested capital base is constrained by the reported net losses.
Bewertungsanalyse
The valuation metrics present a distinct divergence between historical and forward-looking multiples, with a trailing P/E ratio marked as N/A due to negative earnings and a forward P/E of 299.83, implying that the market is pricing in a significant anticipated expansion in future earnings per share. The price-to-book ratio is recorded at 1.18, indicating that the market values the company at a slight premium above its tangible book value, which can be attributed to the intangible value of the lease agreements and portfolio quality. Alternative valuation measures such as the price-to-sales ratio of 6.77 and the EV/EBITDA multiple of 14.70 offer perspective on the company's value relative to its revenue generation and operating cash flow capabilities independent of current net income. The stock has traded within a range defined by a 52-week high of $45.75 and a 52-week low of $29.05, providing a historical volatility context for price analysis. The beta coefficient is 1.20, which signifies that the stock's price volatility is expected to be 20% higher than that of the broader market, reflecting the specific sensitivity of healthcare real estate to interest rate changes and sector-specific demand.
Growth & Income
Revenue growth is projected at 8.6% year-over-year, whereas earnings growth is listed as N/A, indicating that the trajectory of profitability lags behind top-line expansion due to the persistent negative net income in the current reporting period. As a dividend payer, the company offers a dividend yield of 8.3% with a payout ratio of 1114.3%, a figure that mathematically exceeds the reported net income and suggests the dividend is largely funded by cash flow and debt refinancing rather than current earnings retention. The sustainability of this payout is structurally dependent on the strong free cash flow generation rather than the accounting net income, as the payout ratio cannot be sustained solely through earnings retention when net income is negative. Overall, the growth and income profile is characterized by steady revenue expansion coupled with a high-yield dividend strategy that compensates investors for the lack of current accounting profitability and the elevated leverage within the portfolio.